Clinical Trials & Research Teams

Clinical Trials & Research Teams

Advanced, New Therapies and Technology – Early and late-phase studies conducted with participation from our three Drug Development Units and clinics across our practice continue to reveal new discoveries in the use of targeted immunotherapies, radiopharmaceuticals, precision medicine and molecular-based treatments that effectively kill, block or inhibit the growth of cancer cells. The impact of our work is advancing the course of care for cancer patients on a global scale.

Scientific Research Leadership

Lowell Hart MD FACP

Lowell L. Hart, MD, FACP

Bradley Monk

Bradley Monk, MD

Medical Director, Late-Phase Clinical Research

Manish R. Patel, MD

Director of Drug Development

Drug Development Unit – Principal Investigators

Manish R. Patel, MD

Director of Drug Development

Cesar Augusto Perez, MD

Alexander Philipovskiy MD PhD

Alexander Philipovskiy, MD, PhD

Judy Wang, MD

Research South Region – Principal Investigators

Faithlore Gardner, MD

Andres O. Soriano, MD

Fadi Kayali, MD

Scott D. Lunin, MD

Michael J. McCleod, DO, FACOI

Ivor Percent, MD

Syed F. Zafar, MD

Research East Region – Principal Investigators

Shachar Peles, MD

Eric Harris, DO

Marilyn M. Raymond, MD

Avram J. Smukler, MD

Daniel L. Spitz, MD, FACP

Sumithra Vattigunta-Gopal, MD, FACP

Todd A. Gersten, MD

Research North Region – Principal Investigators

Lucio N. Gordan, MD

President & Managing Physician
Disciplinary & Ethics Committee Chair

Maen Hussein, MD

Anjan J. Patel, MD

Audit Committee Chair, Research Office Chair, Pharmacy & Therapeutics Committee Member

Joseph R. Mace, MD

R. Waide Weaver, MD

David D. Wright, MD

Gail Lynn Shaw Wright, MD, FACP, FCCP

Jennifer L. Cultrera, MD

Maria Regina Flores, MD

Sunil Gandhi, MD, FACP

Research Panhandle Region – Principal Investigators

Paresh Patel, MD

Jeffrey A. Bubis, DO, FACOI, FACP

Augusto E. Villegas, MD

Scott Tetreault, MD

Viralkumar Bhanderi, MD